(Q37480050)

20 August 2017

1 reference

title

Taking complement to the clinic--has the time finally come? (English)

1 reference

20 August 2017

P J Lachmann

1

1 reference

20 August 2017

R A G Smith

series ordinal

2

1 reference

20 August 2017

language of work or name

1 reference

1 June 2009

1 reference

Scandinavian Journal of Immunology

20 August 2017

published in

1 reference

20 August 2017

volume

69

1 reference

20 August 2017

issue

6

1 reference

20 August 2017

page(s)

471-478

1 reference

Progress in the development of synthetic thrombin inhibitors as new orally active anticoagulants

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2009.02258.X

Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2009.02258.X

Nontransgenic Hyperexpression of a Complement Regulator in Donor Kidney Modulates Transplant Ischemia/Reperfusion Damage, Acute Rejection, and Chronic Nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2009.02258.X

Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2009.02258.X

Targeting anticomplement agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2009.02258.X

Structural aspects and design of low-molecular-mass complement inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2009.02258.X

10.1111/J.1365-3083.2009.02258.X

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference